One of your subjects is half way through a study of an investigational antidepressant that is injected weekly. the drug requires a taper-down regimen, that is, it should not be stopped abruptly. you learn that the subject will be admitted to prison next week prior to the next scheduled injection. what is the appropriate response for the researcher? a. the researcher should contact the judge in the case, asking that person to intervene. b. tell the subject to let prison authorities know that he is on an investigational medication that cannot be discontinued. c. the researcher should contact prison authorities of the medical issue, and report the events to the irb of record. d. the researcher should remove the subject from the study since it was not approved for prison.